Cargando…

Activation of factor VII-activating protease in human inflammation: a sensor for cell death

INTRODUCTION: Cell death is a central event in the pathogenesis of sepsis and is reflected by circulating nucleosomes. Circulating nucleosomes were suggested to play an important role in inflammation and were demonstrated to correlate with severity and outcome in sepsis patients. We recently showed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stephan, Femke, Hazelzet, Jan A, Bulder, Ingrid, Boermeester, Marja A, van Till, JW Olivier, van der Poll, Tom, Wuillemin, Walter A, Aarden, Lucien A, Zeerleder, Sacha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219388/ https://www.ncbi.nlm.nih.gov/pubmed/21466697 http://dx.doi.org/10.1186/cc10131

Ejemplares similares

Diabetes-independent increase of factor VII-activating protease activation in patients with Gram-negative sepsis (melioidosis)
por: de Jong, H K, et al.
Publicado: (2015)

Increased Nucleosomes and Neutrophil Activation Link to Disease Progression in Patients with Scrub Typhus but Not Murine Typhus in Laos
por: Paris, Daniel H., et al.
Publicado: (2015)

Characterization of the enzymatic activity of the serine protease domain of Factor VII activating protease (FSAP)
por: Nielsen, Nis V., et al.
Publicado: (2019)

Circulating Iron in Patients with Sickle Cell Disease Mediates the Release of Neutrophil Extracellular Traps
por: Van Avondt, Kristof, et al.
Publicado: (2023)

Neutrophil extracellular traps in the host defense against sepsis induced by Burkholderia pseudomallei (melioidosis)
por: de Jong, Hanna K, et al.
Publicado: (2014)

Single-drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients: a systematic review
por: van Till, JW Olivier, et al.
Publicado: (2007)

Plasminogen Activator Inhibitor-1 Is an Inhibitor of Factor VII-activating Protease in Patients with Acute Respiratory Distress Syndrome
por: Wygrecka, Malgorzata, et al.
Publicado: (2007)

Design and Characterization of a New pVII Combinatorial Phage Display Peptide Library for Protease Substrate Mining Using Factor VII Activating Protease (FSAP) as Model
por: Kara, Emrah, et al.
Publicado: (2020)

Complement Factor H-Related Protein 3 Serum Levels Are Low Compared to Factor H and Mainly Determined by Gene Copy Number Variation in CFHR3
por: Pouw, Richard B., et al.
Publicado: (2016)

Factor VII Activating Protease Expression in Human Platelets and Accumulation in Symptomatic Carotid Plaque
por: Parahuleva, Mariana S., et al.
Publicado: (2020)

Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and Mortality
por: Trompet, Stella, et al.
Publicado: (2011)

Type VII Secretion Substrates of Pathogenic Mycobacteria Are Processed by a Surface Protease
por: Burggraaf, Maroeska J., et al.
Publicado: (2019)

Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII/VIIa protease activity
Publicado: (1984)

The effects of tidal volume size and driving pressure levels on pulmonary complement activation: an observational study in critically ill patients
por: de Beer, Friso M., et al.
Publicado: (2020)

The struggle to detect circulating DNA
por: Zeerleder, Sacha
Publicado: (2006)

Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study
por: Schouten, Marcel, et al.
Publicado: (2012)

Neutrophils mitigate the systemic host response during endotoxemia in mice
por: van der Meer, Anne Jan, et al.
Publicado: (2018)

The role of recombinant activated factor VII in cardiac surgery
por: Richardson, A, et al.
Publicado: (2009)

Identification of a Phage Display-Derived Peptide Interacting with the N-Terminal Region of Factor VII Activating Protease (FSAP) Enables Characterization of Zymogen Activation
por: Berge-Seidl, Sebastian, et al.
Publicado: (2022)

Human plasma-derived C1 esterase inhibitor concentrate has limited effect on house dust mite-induced allergic lung inflammation in mice
por: Stroo, Ingrid, et al.
Publicado: (2017)

Compartmentalized anti-inflammatory effects after topical activation of fibinolysis by tissue plasminogen activator in experimental polymicrobial peritonitis
por: van Veen, S, et al.
Publicado: (2005)

Proteolytic activation of the epithelial sodium channel (ENaC) by factor VII activating protease (FSAP) and its relevance for sodium retention in nephrotic mice
por: Artunc, Ferruh, et al.
Publicado: (2021)

Factor VII Activating Protease (FSAP) and Its Importance in Hemostasis—Part I: FSAP Structure, Synthesis and Activity Regulation: A Narrative Review
por: Kwiatkowska, Iga, et al.
Publicado: (2023)

Update on the management of acute pancreatitis
por: van den Berg, Fons F., et al.
Publicado: (2023)

Inhibition of tumour necrosis factor alpha production by activated T cells of rheumatoid arthritis patients by novel anti-folate drugs: an ex vivo pilot study
por: van der Heijden, JW, et al.
Publicado: (2005)

Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis
por: Lin, Cong, et al.
Publicado: (2015)

Protease activated receptor-1 regulates macrophage-mediated cellular senescence: a risk for idiopathic pulmonary fibrosis
por: Lin, Cong, et al.
Publicado: (2015)

Recombinant activated factor VII administration in a patient with congenital lack of factor VII undergoing laparoscopic hysterectomy: A case report
por: Dąbrowski, Filip A., et al.
Publicado: (2021)

Levels of protein C and activated protein C: what do they mean?
por: Hazelzet, Jan A
Publicado: (2006)

Glutaraldehyde-Modified Recombinant Fel d 1: A Hypoallergen With Negligible Biological Activity But Retained Immunogenicity
por: Versteeg, Serge A., et al.
Publicado: (2011)

Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®))
por: Bartosh, Nicole S, et al.
Publicado: (2013)

The G534E polymorphism of the gene encoding the factor VII–activating protease is associated with cardiovascular risk due to increased neointima formation
por: Sedding, Daniel, et al.
Publicado: (2006)

Streptococcus pneumoniae Serine Protease HtrA, but Not SFP or PrtA, Is a Major Virulence Factor in Pneumonia
por: de Stoppelaar, Sacha F., et al.
Publicado: (2013)

Use of recombinant activated factor VII after paediatric cardiac surgery
por: Kharkin, A, et al.
Publicado: (2006)

Author response to: Short- and long-term outcomes of selective use of Frey or extended lateral pancreaticojejunostomy in chronic pancreatitis
por: Kempeneers, Marinus A, et al.
Publicado: (2022)

The effect of Warfarin and factor VII on tissue procoagulant activity and pulmonary seeding.
por: Francis, J. L., et al.
Publicado: (1992)

Overview of the human pharmacokinetics of recombinant activated factor VII
por: Klitgaard, Thomas, et al.
Publicado: (2008)

Treatment of obstetric hemorrhage with recombinant activated factor VII
por: Czuprynski, P, et al.
Publicado: (2009)

Recombinant activated factor VII in post partum haemorrhage
por: Magon, Navneet, et al.
Publicado: (2013)

A candidate activation pathway for coagulation factor VII
por: Misenheimer, Tina M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iorsl8i5e9l05ul5hg4qbfom0n